Skip to main content

Table 1 Patients' characteristics

From: Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR)

Characteristic

 

Sex (male)

403/446 (90.4)

Age (years)

63.9 (11.6)

Employment

 

   Employed

137 (30.7)

   Unemployed

28 (6.3)

   Retired

226 (59.6)

   Unknown/not declared

15 (3.4)

Education

 

   No or primary

158 (35.9)

   Secondary

121 (27.5)

   Upper secondary

123 (27.9)

   Tertiary

38 (8.6)

Current smokers

72/444 (16.2)

Body mass index

28.0 (4.1)

High alcohol consumers

160 (36.4)

Comorbidities

3 (1 to 4)

   Hypertension

313 (70.3)

   Renal failure

73 (16.4)

   Osteoarthritis

249 (55.9)

   Cardiovascular disorders

119 (26.8)

   Diabetes

64 (14.4)

   Liver disorders

36 (8.1)

   Neoplasms

28 (6.29)

Sangha comorbidity index (0 to 36)

4 (2 to 7)

Fulfils preliminary ACR criteria

411/445 (92.4)

Disease duration (years)

3.8 (1.5 to 10.1)

Joint involvement

 

   Monoarticular (1 joint)

95(21.5)

   Oligoarticular (2 to 4 joints)

264 (59.7)

   Polyarticular (>4 joints)

83 (18.8)

Swollen joints (0 to 66)

0 (0 to 1)

Tender joints (0 to 68)

1 (0 to 3)

Presence of tophia

87 (19.9)

Number of flares (12 months)

1 (0 to 3)

Flare (previous month)

132 (29.9)

Serum urate level (mg/dl)b

6.3 (1.7)

Previous corticosteroids

125 (28.0)

Current NSAIDs or colchicine

189 (42.4)

Allopurinol

303 (67.9)

Febuxostat

60 (13.4)

  1. Data presented as n (%), mean (standard deviation) or median (interquartile range). ACR, American College of Rheumatology; NSAID, nonsteroidal anti-inflammatory drug. Data available for a437 subjects and b410 subjects.